TabletsTablets
Schedule H (Prescription Required)Antidepressants & Mood StabilizersCode: 2864

Tianeptine Tablet (12.5 Mg)

Generic Formulation:Tianeptine Tablet (12.5 Mg)
Pack Size:10's

MRP Under Process

Official PMBI MRP is being updated for catalog code 2864.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Tianeptine is an atypical psychotropic agent with neuroprotective and glutamatergic modulating actions. In contrast to classical antidepressants, it acts as a full agonist at the mu-opioid receptor (MOR) and modulates AMPA/NMDA glutamate receptor phosphorylation in the hippocampus and amygdala, reversing stress-induced dendritic atrophy. Indicated for mild, moderate, or severe depressive episodes, dysthymia, and anxiety associated with somatic disorders.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2864.Report inaccuracy

Usage Guidelines

Take orally three times daily (morning, noon, and evening) immediately before main meals with water. Complete the prescribed course. Do not exceed recommended doses.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Abdominal pain, dry mouth, nausea, constipation, insomnia, drowsiness, headache, tachycardia. Rare/Severe: Dependence, abuse liability, withdrawal symptoms upon abrupt cessation, and hepatotoxicity.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Potential for abuse and dependence; avoid in patients with history of substance use disorder. Contraindicated with MAO inhibitors (requires 2-week washout). Taper gradually over 7 to 14 days when stopping.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.